What Happens to the Immune Microenvironment After PD-1 Inhibitor Therapy?

The fruitful results of tumor immunotherapy establish its indispensable status in the regulation of the tumorous immune context. It seems that the treatment of programmed cell death receptor 1 (PD-1) blockade is one of the most promising approaches for cancer control. The significant efficacy of PD-...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Qingyi Wang, Bin Xie, Shuang Liu, Ying Shi, Yongguang Tao, Desheng Xiao, Wenxiang Wang
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2021-12-01
Serija:	Frontiers in Immunology
Teme:	immunotherapy PD-1 inhibitor tumor microenvironment cytotoxic T lymphocytes (CTLs) immunotherapy resistance combined immunotherapy
Online dostop:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.773168/full
Oznake:	Označite Brez oznak, prvi označite!